Clinical Trials Browser

Phase 1/2 × Advanced Non Small Cell Lung Cancer × pembrolizumab × Clear all

NCT04032847 2025-03-10

ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

Phase 1/2 Terminated

27 enrolled 12 charts

Advanced Non Small Cell Lung Cancer